Why is Kabra Drugs Ltd ?
1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0%
- Low ability to service debt as the company has a high Debt to EBITDA ratio of -0.27 times
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
No Data Found
Quality key factors
Factor
Value
Sales Growth (5y)
9,274.00%
EBIT Growth (5y)
404.05%
EBIT to Interest (avg)
0.60
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.43
Sales to Capital Employed (avg)
0.01
Tax Ratio
13.29%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
-26.76%
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
11
Industry P/E
33
Price to Book Value
2.12
EV to EBIT
8.33
EV to EBITDA
8.22
EV to Capital Employed
2.95
EV to Sales
0.47
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
35.42%
ROE (Latest)
19.08%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Movement
24What is working for the Company
NET SALES(Latest six months)
Higher at Rs 65.83 cr
PAT(Latest six months)
Higher at Rs 3.63 cr
PBT LESS OI(Q)
At Rs 1.31 cr has Grown at 42.4% (vs previous 4Q average
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Kabra Drugs
Net Sales - Latest six months
At Rs 65.83 cr has Grown at 6,582,999,900.00%
Year on Year (YoY)MOJO Watch
Sales trend is very positive
Net Sales (Rs Cr)
Profit After Tax (PAT) - Latest six months
At Rs 3.63 cr has Grown at 2,520.00%
Year on Year (YoY)MOJO Watch
PAT trend is very positive
PAT (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 1.31 cr has Grown at 42.4% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 0.92 CrMOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Net Sales - Latest six months
Higher at Rs 65.83 cr
than preceding 12 month period ended Mar 2026 of Rs 26.91 crMOJO Watch
In the half year the company has already crossed sales of the previous twelve months
Net Sales (Rs Cr)
Profit After Tax (PAT) - Latest six months
Higher at Rs 3.63 cr
than preceding 12 month period ended Mar 2026 of Rs 1.19 crMOJO Watch
In the half year the company has already crossed PAT of the previous twelve months
PAT (Rs Cr)






